查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1876483

全EXOME定序市場：全球產業分析、規模、佔有率、成長、趨勢與預測（2025-2032）

Whole Exome Sequencing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 180 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research近期發布了一份關於全球全EXOME序（WES）市場的綜合報告。該報告深入分析了市場結構，並對關鍵市場動態進行了全面評估，包括促進因素、趨勢、機會和挑戰。該研究報告提供了獨家數據和統計資訊，展現了2025年至2032年全球全EXOME組測序市場的預期成長軌跡。

主要發現：

  • 全EXOME定序市場規模（2025年）：21.735億美元
  • 預計市場價值（2032年）：68.796億美元
  • 全球市場成長率（2025年至2032年複合年成長率）：17.9%

全EXOME市場—研究範圍：

全EXOME定序在遺傳疾病研究中發揮關鍵作用，為疾病機制和潛在治療方法提供了寶貴的見解。 WES市場面向醫院、研究機構、實驗室和臨床機構，提供各種定序服務和解決方案。市場成長的驅動力包括定序技術的進步、成本的下降以及對精準醫療、基因檢測和個人化醫療日益成長的需求。

市場成長促進因素：

全球全EXOME定序市場受多種關鍵因素驅動，包括遺傳疾病盛行率的上升和對個人化醫療日益成長的需求。基因組研究的日益重視、新一代定序（NGS）等定序技術的進步以及定序成本的下降也推動了市場擴張。此外，全外顯子定序在癌症研究、罕見疾病診斷和藥物研發的應用也促進了EXOME序服務的普及。同時，政府投入的增加和基因檢測平台的擴展也為市場參與者帶來了新的機會。

市場限制：

儘管全EXOME定序市場前景廣闊，但仍面臨高成本、倫理問題和監管障礙等挑戰。數據分析和結果解讀的複雜性可能成為其廣泛應用的重大障礙，尤其是在資源匱乏的地區。此外，資料隱私、病患知情同意以及基因檢測的倫理挑戰等問題也持續困擾著相關人員。將基因組數據整合到臨床實踐中也存在許多挑戰，需要醫療服務提供者、政策制定者和研究人員之間的合作。

市場機會：

由於人工智慧 (AI) 在基因組數據分析中的應用、罕見遺傳疾病研究的拓展以及對個人化治療策略需求的日益成長，全EXOME組定序市場展現出巨大的成長潛力。可攜式、低成本定序儀和就地檢驗平台的開發有望為市場參與者開闢新的道路。此外，對伴隨診斷的日益重視以及基於基因組數據的標靶治療的開發，預計也將推動全EXOME序服務的需求。

本報告解答的關鍵問題：

  • 推動全球全EXOME顯子定序市場成長的關鍵因素有哪些？
  • 定序技術的進步如何影響全EXOME定序的應用？
  • WES在醫療和研究領域的主要應用有哪些？
  • 哪些公司是全EXOME定序市場的主要企業貢獻者？它們正在採取哪些策略來維持其市場地位？
  • 全球全EXOME定序市場有哪些新興趨勢與未來前景？

目錄

第1章執行摘要

第2章 市場概覽

  • 市場範圍和定義
  • 市場動態
    • 促進要素
    • 抑制因素
    • 機會
    • 主要趨勢
  • 宏觀經濟因素
    • 全球產業展望
    • 全球GDP成長預測
  • 新冠疫情影響分析
  • 預測因子：相關性和影響

第3章 加值見解

  • 產品採納分析
  • 監管狀態
  • 波特五力分析
  • PESTLE分析
  • 主要企業的促銷策略

第4章 定價分析，2025年

  • 主要亮點
  • 影響產品價格的關鍵因素
  • 產品價格分析
  • 區域價格和產品偏好

5. 全球全EXOME定序市場展望

  • 主要亮點
    • 市場規模預測
    • 市場規模和年成長率
    • 絕對商機
  • 市場規模分析與預測
    • 2019-2024年歷史市場規模與交易量分析
    • 市場規模及銷售分析及預測（2025-2032年）
  • 全球全EXOME定序市場展望：產品
    • 引言/主要發現
    • 按產品分類的歷史市場規模與銷售分析（2019-2024 年）
    • 市場規模及銷售分析及預測（依產品分類），2025-2032年
      • 裝置
      • 消耗品
      • 軟體和服務
    • 市場吸引力分析：產品
  • 全球全EXOME市場展望：應用
    • 引言/主要發現
    • 按應用領域分類的歷史市場規模，2019-2024 年
    • 按應用領域分類的市場規模分析與預測（2025-2032年）
      • 藥物發現與開發
      • 臨床診斷
      • 個人化醫療
      • 其他
    • 市場吸引力分析：應用
  • 全球全EXOME市場展望：技術
    • 引言/主要發現
    • 按技術分類的歷史市場規模，2019-2024 年
    • 依技術分類的市場規模分析及預測（2025-2032 年）
      • ION半導體序列
      • 合成定序
      • 其他
    • 市場吸引力分析：技術
  • 全球全EXOME市場展望：終端用戶
    • 引言/主要發現
    • 按最終用戶分類的歷史市場規模，2019-2024 年
    • 依最終用戶分類的市場規模分析及預測（2025-2032 年）
      • 醫院和診斷檢查室
      • 製藥和生物技術公司
      • 合約研究組織（CRO）
      • 學術研究機構
      • 其他
    • 市場吸引力分析：最終用戶

6. 全球全EXOME市場區域展望

  • 主要亮點
  • 按地區分類的歷史市場規模分析（2019-2024 年）
  • 市場規模分析及預測（依地區分類，2025-2032年）
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：區域

7. 北美全EXOME定序市場展望

8. 歐洲全EXOME定序市場展望

9. 東亞全EXOME定序市場展望

10. 南亞和大洋洲全EXOME定序市場展望

11. 拉丁美洲全EXOME定序市場展望

12. 中東和非洲全外EXOME市場展望

第13章 競爭格局

  • 2025年市佔率分析
  • 市場結構
    • 市場競爭加劇地圖
    • 競爭對手儀錶板
  • 公司簡介（詳情：概述、財務狀況、策略、近期發展）
    • CD Genomics
    • Eurofins Genomics
    • GENEWIZ（Azenta Life Sciences）
    • Illumina, Inc.
    • Integrated DNA Technologies, Inc.
    • Blueprint Genetics Oy
    • Caris Life Sciences
    • MedGenome
    • Psomagen
    • 3billion, Inc.
    • BGI
    • Mapmygenome
    • Almac Group
    • CeGaT GmbH
    • Novogene Co., Ltd
    • ONEOMICS
    • Celemics, Inc.
    • Dreamgenics, SL
    • Gene by Gene, Ltd
    • VERITAS INTERCONTINENTAL
    • Laboratory Corporation of America（R）Holdings
    • Revvity
    • Thermo Fisher Scientific Inc.

第14章附錄

  • 調查方法
  • 調查先決條件
  • 首字母縮寫和簡稱
簡介目錄
Product Code: PMRREP3193

Persistence Market Research has recently released a comprehensive report on the worldwide market for whole exome sequencing (WES). The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global whole exome sequencing market from 2025 to 2032.

Key Insights:

  • Whole Exome Sequencing Market Size (2025E): USD 2,173.5 Million
  • Projected Market Value (2032F): USD 6,879.6 Million
  • Global Market Growth Rate (CAGR 2025 to 2032): 17.9%

Whole Exome Sequencing Market - Report Scope:

Whole exome sequencing plays a crucial role in the study of genetic diseases, providing valuable insights into disease mechanisms and potential treatments. The WES market caters to hospitals, research institutions, academic laboratories, and clinical settings, offering a range of sequencing services and solutions. Market growth is driven by advancements in sequencing technologies, decreasing costs, and an increasing demand for precision medicine, genetic testing, and personalized healthcare.

Market Growth Drivers:

The global whole exome sequencing market is propelled by several key factors, including the rising prevalence of genetic disorders and the growing demand for personalized medicine. The increasing focus on genomic research, advancements in sequencing technologies like next-generation sequencing (NGS), and decreasing costs of sequencing are further fueling market expansion. Additionally, the use of WES in cancer research, rare disease diagnosis, and drug development contributes to the growing adoption of exome sequencing services. Moreover, the increased government funding and the expansion of genetic testing platforms provide new opportunities for market players.

Market Restraints:

Despite promising growth prospects, the whole exome sequencing market faces challenges related to high costs, ethical concerns, and regulatory hurdles. The complexity of data analysis and the interpretation of results can be significant barriers to widespread adoption, particularly in resource-limited settings. Additionally, issues around data privacy, patient consent, and the ethical implications of genetic testing present ongoing challenges for stakeholders. The market also faces challenges in terms of the integration of genomic data into clinical practice, requiring collaboration among healthcare providers, policymakers, and researchers.

Market Opportunities:

The whole exome sequencing market presents significant growth opportunities driven by the integration of artificial intelligence (AI) in genomic data analysis, expanding research in rare genetic diseases, and the growing demand for personalized treatment strategies. The development of portable and cost-effective sequencing devices and platforms for point-of-care testing is expected to create new avenues for market players. Furthermore, the increasing focus on companion diagnostics and the development of targeted therapies based on genomic data will drive demand for whole exome sequencing services.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the whole exome sequencing market globally?
  • How are advancements in sequencing technologies shaping the adoption of whole exome sequencing?
  • What are the major applications of WES across healthcare and research settings?
  • Who are the key players contributing to the whole exome sequencing market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global whole exome sequencing market?

Competitive Intelligence and Business Strategy:

Leading players in the global whole exome sequencing market, including Illumina, Thermo Fisher Scientific, and Agilent Technologies, focus on innovation, product differentiation, and strategic collaborations to maintain a competitive edge. These companies invest in research and development to advance sequencing technologies, improve accuracy, and lower sequencing costs. Collaborations with academic institutions, healthcare providers, and biotechnology companies facilitate market access and promote the adoption of WES technologies. Additionally, the emphasis on personalized medicine and targeted therapies drives further research and investment into the WES market.

Key Companies Profiled:

  • CD Genomics
  • Eurofins Genomics
  • GENEWIZ (Azenta Life Sciences)
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Blueprint Genetics Oy
  • Caris Life Sciences
  • MedGenome
  • Psomagen
  • 3billion, Inc.
  • BGI
  • Mapmygenome
  • Almac Group
  • CeGaT GmbH
  • Novogene Co., Ltd
  • ONEOMICS
  • Celemics, Inc.
  • Dreamgenics, S.L.
  • Gene by Gene, Ltd
  • VERITAS INTERCONTINENTAL
  • Laboratory Corporation of America(R) Holdings
  • Revvity
  • Thermo Fisher Scientific Inc.

Whole Exome Sequencing Market Research Segmentation:

The whole exome sequencing market encompasses a diverse range of products, technologies, applications, and end-user segments, addressing various healthcare needs and research fields.

By Product:

  • Instruments
  • Consumables
  • Software and Services

By Application:

  • Drug Discovery & Development
  • Clinical Diagnostics
  • Personalized Medicines
  • Others

By Technology:

  • ION Semiconductor Sequencing
  • Sequencing by Synthesis
  • Others

By End-User:

  • Hospitals & Diagnostic Laboratories
  • Pharma & Biotech Companies
  • Contract Research Organizations (CROs)
  • Academic and Research Institutes
  • Others

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Whole Exome Sequencing Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Porter's Five Forces Analysis
  • 3.4. PESTLE Analysis
  • 3.5. Promotional Strategies, By Key Players

4. Price Analysis, 2025A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product
  • 4.4. Regional Prices and Product Preferences

5. Global Whole Exome Sequencing Market Outlook

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Mn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Mn) and Volume (Units) Analysis, 2019-2024
    • 5.2.2. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, 2025-2032
  • 5.3. Global Whole Exome Sequencing Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2024
    • 5.3.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
      • 5.3.3.1. Instruments
      • 5.3.3.2. Consumables
      • 5.3.3.3. Software & Services
    • 5.3.4. Market Attractiveness Analysis: Product
  • 5.4. Global Whole Exome Sequencing Market Outlook: Application
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Mn), By Application, 2019-2024
    • 5.4.3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
      • 5.4.3.1. Drug Discovery & Development
      • 5.4.3.2. Clinical Diagnostics
      • 5.4.3.3. Personalized Medicines
      • 5.4.3.4. Others
    • 5.4.4. Market Attractiveness Analysis: Application
  • 5.5. Global Whole Exome Sequencing Market Outlook: Technology
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Mn), By Technology, 2019-2024
    • 5.5.3. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
      • 5.5.3.1. ION Semiconductor Sequencing
      • 5.5.3.2. Sequencing by Synthesis
      • 5.5.3.3. Others
    • 5.5.4. Market Attractiveness Analysis: Technology
  • 5.6. Global Whole Exome Sequencing Market Outlook: End User
    • 5.6.1. Introduction / Key Findings
    • 5.6.2. Historical Market Size (US$ Mn), By End User, 2019-2024
    • 5.6.3. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
      • 5.6.3.1. Hospitals & Diagnostic Laboratories
      • 5.6.3.2. Pharma & Biotech Companies
      • 5.6.3.3. Contract Research Organizations (CROs)
      • 5.6.3.4. Academic and Research Institutions
      • 5.6.3.5. Others
    • 5.6.4. Market Attractiveness Analysis: End User

6. Global Whole Exome Sequencing Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
  • 6.3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Whole Exome Sequencing Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Application
    • 7.2.4. By Technology
    • 7.2.5. By End User
  • 7.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 7.4.1. Instruments
    • 7.4.2. Consumables
    • 7.4.3. Software & Services
  • 7.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 7.5.1. Drug Discovery & Development
    • 7.5.2. Clinical Diagnostics
    • 7.5.3. Personalized Medicines
    • 7.5.4. Others
  • 7.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 7.6.1. ION Semiconductor Sequencing
    • 7.6.2. Sequencing by Synthesis
    • 7.6.3. Others
  • 7.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 7.7.1. Hospitals & Diagnostic Laboratories
    • 7.7.2. Pharma & Biotech Companies
    • 7.7.3. Contract Research Organizations (CROs)
    • 7.7.4. Academic and Research Institutions
    • 7.7.5. Others
  • 7.8. Market Attractiveness Analysis

8. Europe Whole Exome Sequencing Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By Technology
    • 8.2.5. By End User
  • 8.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 8.4.1. Instruments
    • 8.4.2. Consumables
    • 8.4.3. Software & Services
  • 8.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 8.5.1. Drug Discovery & Development
    • 8.5.2. Clinical Diagnostics
    • 8.5.3. Personalized Medicines
    • 8.5.4. Others
  • 8.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 8.6.1. ION Semiconductor Sequencing
    • 8.6.2. Sequencing by Synthesis
    • 8.6.3. Others
  • 8.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 8.7.1. Hospitals & Diagnostic Laboratories
    • 8.7.2. Pharma & Biotech Companies
    • 8.7.3. Contract Research Organizations (CROs)
    • 8.7.4. Academic and Research Institutions
    • 8.7.5. Others
  • 8.8. Market Attractiveness Analysis

9. East Asia Whole Exome Sequencing Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By Technology
    • 9.2.5. By End User
  • 9.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 9.4.1. Instruments
    • 9.4.2. Consumables
    • 9.4.3. Software & Services
  • 9.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 9.5.1. Drug Discovery & Development
    • 9.5.2. Clinical Diagnostics
    • 9.5.3. Personalized Medicines
    • 9.5.4. Others
  • 9.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 9.6.1. ION Semiconductor Sequencing
    • 9.6.2. Sequencing by Synthesis
    • 9.6.3. Others
  • 9.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 9.7.1. Hospitals & Diagnostic Laboratories
    • 9.7.2. Pharma & Biotech Companies
    • 9.7.3. Contract Research Organizations (CROs)
    • 9.7.4. Academic and Research Institutions
    • 9.7.5. Others
  • 9.8. Market Attractiveness Analysis

10. South Asia & Oceania Whole Exome Sequencing Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By Technology
    • 10.2.5. By End User
  • 10.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 10.4.1. Instruments
    • 10.4.2. Consumables
    • 10.4.3. Software & Services
  • 10.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 10.5.1. Drug Discovery & Development
    • 10.5.2. Clinical Diagnostics
    • 10.5.3. Personalized Medicines
    • 10.5.4. Others
  • 10.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 10.6.1. ION Semiconductor Sequencing
    • 10.6.2. Sequencing by Synthesis
    • 10.6.3. Others
  • 10.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 10.7.1. Hospitals & Diagnostic Laboratories
    • 10.7.2. Pharma & Biotech Companies
    • 10.7.3. Contract Research Organizations (CROs)
    • 10.7.4. Academic and Research Institutions
    • 10.7.5. Others
  • 10.8. Market Attractiveness Analysis

11. Latin America Whole Exome Sequencing Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By Technology
    • 11.2.5. By End User
  • 11.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 11.4.1. Instruments
    • 11.4.2. Consumables
    • 11.4.3. Software & Services
  • 11.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 11.5.1. Drug Discovery & Development
    • 11.5.2. Clinical Diagnostics
    • 11.5.3. Personalized Medicines
    • 11.5.4. Others
  • 11.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 11.6.1. ION Semiconductor Sequencing
    • 11.6.2. Sequencing by Synthesis
    • 11.6.3. Others
  • 11.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 11.7.1. Hospitals & Diagnostic Laboratories
    • 11.7.2. Pharma & Biotech Companies
    • 11.7.3. Contract Research Organizations (CROs)
    • 11.7.4. Academic and Research Institutions
    • 11.7.5. Others
  • 11.8. Market Attractiveness Analysis

12. Middle East & Africa Whole Exome Sequencing Market Outlook

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 12.2.1. By Country
    • 12.2.2. By Product
    • 12.2.3. By Application
    • 12.2.4. By Technology
    • 12.2.5. By End User
  • 12.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 12.4.1. Instruments
    • 12.4.2. Consumables
    • 12.4.3. Software & Services
  • 12.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 12.5.1. Drug Discovery & Development
    • 12.5.2. Clinical Diagnostics
    • 12.5.3. Personalized Medicines
    • 12.5.4. Others
  • 12.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 12.6.1. ION Semiconductor Sequencing
    • 12.6.2. Sequencing by Synthesis
    • 12.6.3. Others
  • 12.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 12.7.1. Hospitals & Diagnostic Laboratories
    • 12.7.2. Pharma & Biotech Companies
    • 12.7.3. Contract Research Organizations (CROs)
    • 12.7.4. Academic and Research Institutions
    • 12.7.5. Others
  • 12.8. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. CD Genomics
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Products
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Eurofins Genomics
    • 13.3.3. GENEWIZ (Azenta Life Sciences)
    • 13.3.4. Illumina, Inc.
    • 13.3.5. Integrated DNA Technologies, Inc.
    • 13.3.6. Blueprint Genetics Oy
    • 13.3.7. Caris Life Sciences
    • 13.3.8. MedGenome
    • 13.3.9. Psomagen
    • 13.3.10. 3billion, Inc.
    • 13.3.11. BGI
    • 13.3.12. Mapmygenome
    • 13.3.13. Almac Group
    • 13.3.14. CeGaT GmbH
    • 13.3.15. Novogene Co., Ltd
    • 13.3.16. ONEOMICS
    • 13.3.17. Celemics, Inc.
    • 13.3.18. Dreamgenics, S.L.
    • 13.3.19. Gene by Gene, Ltd
    • 13.3.20. VERITAS INTERCONTINENTAL
    • 13.3.21. Laboratory Corporation of America(R) Holdings
    • 13.3.22. Revvity
    • 13.3.23. Thermo Fisher Scientific Inc.

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations